Skip to main content Back to Top
Advertisement

6/24/2019

Clotrimazole Lozenges (Clotrimazole Troches)

Products Affected - Description

    • Clotrimazole oral troche, Hikma, 10 mg, bottle, 70 count, NDC 00054-4146-22
    • Clotrimazole oral troche, Hikma, 10 mg, bottle, 140 count, NDC 00054-4146-23
    • Clotrimazole oral troche, Hikma, 10 mg, unit-dose blister pack, 70 count, NDC 00054-8146-22
    • Clotrimazole oral troche, Perrigo, 10 mg, bottle, 70 count, NDC 00574-0107-70
    • Clotrimazole oral troche, Perrigo, 10 mg, bottle, 140 count, NDC 00574-0107-14
    • Clotrimazole oral troche, Perrigo, 10 mg, unit-dose blister pack, 70 count, NDC 00574-0107-77

Reason for the Shortage

    • Hikma did not provide a reason for the shortage.
    • Perrigo has clotrimazole lozenges on shortage due to increased demand.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Hikma has clotrimazole 10 mg lozenges in 70 count and 140 count bottles on allocation. The 10 mg lozenges in 70 count unit-dose packs are on allocation.
    • Perrigo has clotrimazole 10 mg lozenges in 70 count bottles on back order and the company estimates a release date of August 2019. The 10 mg lozenges in 140 count bottles are on back order and the company estimates a release date of September 2019. The 10 mg lozenges in 70 count unit-dose packs are on back order and the company estimates a release date of September 2019.

Updated

Updated June 24, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 5, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins